CN110129281A - 一种使用悬浮细胞培养新城疫病毒的方法及应用 - Google Patents
一种使用悬浮细胞培养新城疫病毒的方法及应用 Download PDFInfo
- Publication number
- CN110129281A CN110129281A CN201910409203.9A CN201910409203A CN110129281A CN 110129281 A CN110129281 A CN 110129281A CN 201910409203 A CN201910409203 A CN 201910409203A CN 110129281 A CN110129281 A CN 110129281A
- Authority
- CN
- China
- Prior art keywords
- newcastle disease
- disease virus
- culture
- cell
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000711404 Avian avulavirus 1 Species 0.000 title claims abstract description 56
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000004113 cell culture Methods 0.000 title claims abstract description 22
- 239000000725 suspension Substances 0.000 title claims abstract description 21
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims abstract description 37
- 231100000614 poison Toxicity 0.000 claims abstract description 24
- 239000002574 poison Substances 0.000 claims abstract description 24
- 239000001963 growth medium Substances 0.000 claims abstract description 18
- 101100269369 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) AGE1 gene Proteins 0.000 claims abstract description 16
- 239000002609 medium Substances 0.000 claims abstract description 14
- 108010019160 Pancreatin Proteins 0.000 claims abstract description 10
- 229940055695 pancreatin Drugs 0.000 claims abstract description 10
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 239000005723 virus inoculator Substances 0.000 claims description 5
- 239000006285 cell suspension Substances 0.000 claims description 2
- 238000012549 training Methods 0.000 claims description 2
- 230000003612 virological effect Effects 0.000 abstract description 15
- 238000012258 culturing Methods 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 2
- 238000004114 suspension culture Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 64
- 241000700605 Viruses Species 0.000 description 36
- 241000287828 Gallus gallus Species 0.000 description 27
- 235000013330 chicken meat Nutrition 0.000 description 27
- 208000010359 Newcastle Disease Diseases 0.000 description 19
- 239000000243 solution Substances 0.000 description 18
- 102000004142 Trypsin Human genes 0.000 description 16
- 108090000631 Trypsin Proteins 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 239000012588 trypsin Substances 0.000 description 16
- 229960005486 vaccine Drugs 0.000 description 16
- 231100000167 toxic agent Toxicity 0.000 description 11
- 239000003440 toxic substance Substances 0.000 description 11
- 238000011081 inoculation Methods 0.000 description 9
- 230000001779 embryotoxic effect Effects 0.000 description 8
- 231100000238 embryotoxicity Toxicity 0.000 description 8
- 210000001161 mammalian embryo Anatomy 0.000 description 7
- 238000003306 harvesting Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000010257 thawing Methods 0.000 description 6
- 230000036039 immunity Effects 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 230000005847 immunogenicity Effects 0.000 description 4
- 229940031551 inactivated vaccine Drugs 0.000 description 4
- 238000001514 detection method Methods 0.000 description 3
- 210000002257 embryonic structure Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 241000272525 Anas platyrhynchos Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 238000009361 aviculture Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000007918 pathogenicity Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 101150084750 1 gene Proteins 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 229940028617 conventional vaccine Drugs 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 101150088856 pix gene Proteins 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000013587 production medium Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18151—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910409203.9A CN110129281A (zh) | 2019-05-15 | 2019-05-15 | 一种使用悬浮细胞培养新城疫病毒的方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910409203.9A CN110129281A (zh) | 2019-05-15 | 2019-05-15 | 一种使用悬浮细胞培养新城疫病毒的方法及应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110129281A true CN110129281A (zh) | 2019-08-16 |
Family
ID=67574805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910409203.9A Pending CN110129281A (zh) | 2019-05-15 | 2019-05-15 | 一种使用悬浮细胞培养新城疫病毒的方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110129281A (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111569060A (zh) * | 2020-05-07 | 2020-08-25 | 成都天邦生物制品有限公司 | 一种鸡产蛋下降综合征疫苗的制备方法及疫苗 |
CN111671892A (zh) * | 2020-05-07 | 2020-09-18 | 成都天邦生物制品有限公司 | 全悬浮鸭胚视网膜细胞在鸡产蛋下降综合症疫苗中的应用 |
CN112156182A (zh) * | 2020-11-10 | 2021-01-01 | 成都天邦生物制品有限公司 | 一种全悬浮细胞源鸡新城疫、禽流感二联灭活疫苗 |
CN112251415A (zh) * | 2020-09-21 | 2021-01-22 | 成都天邦生物制品有限公司 | 一种鸡新城疫病毒分离方法 |
CN112359142A (zh) * | 2020-11-10 | 2021-02-12 | 成都天邦生物制品有限公司 | 一种使用全悬浮细胞测定鸡新城疫病毒含量的方法 |
CN112626123A (zh) * | 2020-12-31 | 2021-04-09 | 华农(肇庆)生物产业技术研究院有限公司 | 重组质粒、重组基因vii型新城疫病毒及其培养方法 |
CN113122508A (zh) * | 2021-03-30 | 2021-07-16 | 成都天邦生物制品有限公司 | 一株鸡传染性支气管炎细胞适应毒及其应用 |
CN113699119A (zh) * | 2020-12-10 | 2021-11-26 | 华农(肇庆)生物产业技术研究院有限公司 | 一种新城疫病毒及疫苗的无血清全悬浮培养制备方法 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007010858A1 (ja) * | 2005-07-15 | 2007-01-25 | Kyoto University | 骨格筋組織由来の単一細胞よりクローン化した多能性幹細胞 |
WO2011098615A1 (fr) * | 2010-02-15 | 2011-08-18 | Universite Claude Bernard Lyon 1 | Cellules modifiees pour la production virale par l'inhibition du gene hipk2 |
WO2011139717A1 (en) * | 2010-04-26 | 2011-11-10 | Novartis Ag | Improved production of virus replicon particles in packaging cells |
CN104721817A (zh) * | 2013-12-19 | 2015-06-24 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物及其制备方法和应用 |
CN105861421A (zh) * | 2016-06-24 | 2016-08-17 | 济南磐升生物技术有限公司 | 一种多功能无血清细胞培养基及其应用 |
CN106729690A (zh) * | 2017-03-08 | 2017-05-31 | 广州博恒生物科技有限公司 | 鸡新城疫、禽流感病毒和禽腺病毒三联灭活疫苗的制备方法 |
CN106987554A (zh) * | 2017-04-17 | 2017-07-28 | 广东顺德工业设计研究院(广东顺德创新设计研究院) | 悬浮细胞株及其驯化方法 |
CN108220227A (zh) * | 2017-12-27 | 2018-06-29 | 华农(肇庆)生物产业技术研究院有限公司 | 一种通过全悬浮传代细胞系悬浮培养新城疫病毒的方法 |
CN108603188A (zh) * | 2015-11-24 | 2018-09-28 | 联邦科学技术研究组织 | 在细胞培养物中产生病毒 |
CN112156182A (zh) * | 2020-11-10 | 2021-01-01 | 成都天邦生物制品有限公司 | 一种全悬浮细胞源鸡新城疫、禽流感二联灭活疫苗 |
CN113122508A (zh) * | 2021-03-30 | 2021-07-16 | 成都天邦生物制品有限公司 | 一株鸡传染性支气管炎细胞适应毒及其应用 |
-
2019
- 2019-05-15 CN CN201910409203.9A patent/CN110129281A/zh active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007010858A1 (ja) * | 2005-07-15 | 2007-01-25 | Kyoto University | 骨格筋組織由来の単一細胞よりクローン化した多能性幹細胞 |
WO2011098615A1 (fr) * | 2010-02-15 | 2011-08-18 | Universite Claude Bernard Lyon 1 | Cellules modifiees pour la production virale par l'inhibition du gene hipk2 |
WO2011139717A1 (en) * | 2010-04-26 | 2011-11-10 | Novartis Ag | Improved production of virus replicon particles in packaging cells |
CN104721817A (zh) * | 2013-12-19 | 2015-06-24 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物及其制备方法和应用 |
CN108603188A (zh) * | 2015-11-24 | 2018-09-28 | 联邦科学技术研究组织 | 在细胞培养物中产生病毒 |
CN105861421A (zh) * | 2016-06-24 | 2016-08-17 | 济南磐升生物技术有限公司 | 一种多功能无血清细胞培养基及其应用 |
CN106729690A (zh) * | 2017-03-08 | 2017-05-31 | 广州博恒生物科技有限公司 | 鸡新城疫、禽流感病毒和禽腺病毒三联灭活疫苗的制备方法 |
CN106987554A (zh) * | 2017-04-17 | 2017-07-28 | 广东顺德工业设计研究院(广东顺德创新设计研究院) | 悬浮细胞株及其驯化方法 |
CN108220227A (zh) * | 2017-12-27 | 2018-06-29 | 华农(肇庆)生物产业技术研究院有限公司 | 一种通过全悬浮传代细胞系悬浮培养新城疫病毒的方法 |
CN112156182A (zh) * | 2020-11-10 | 2021-01-01 | 成都天邦生物制品有限公司 | 一种全悬浮细胞源鸡新城疫、禽流感二联灭活疫苗 |
CN113122508A (zh) * | 2021-03-30 | 2021-07-16 | 成都天邦生物制品有限公司 | 一株鸡传染性支气管炎细胞适应毒及其应用 |
Non-Patent Citations (6)
Title |
---|
ISMAILA SHITTU等: "Development, characterization and optimization of a new suspension chicken-induced pluripotent cell line for the production of Newcastle disease vaccine", 《BIOLOGICALS》 * |
V.LOHR等: "New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: Studies on growth, metabolism and virus propagation", 《VACCINE》 * |
刘斌主编: "《细胞培养》", 31 January 2018, 世界图书出版公司 * |
刘长清等: "鸡新城疫( 基因Ⅶ型) 、禽流感( H9 亚型) 二联灭活疫苗 ( aSG10 株 + G 株) 在蛋鸡上的安全性及免疫效果研究", 《中国兽医杂志》 * |
赵亮: "293细胞无血清培养基及结团特性研究", 《道客巴巴在线文档分享平台》 * |
赵广英主编, 东北林业大学出版社 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111569060A (zh) * | 2020-05-07 | 2020-08-25 | 成都天邦生物制品有限公司 | 一种鸡产蛋下降综合征疫苗的制备方法及疫苗 |
CN111671892A (zh) * | 2020-05-07 | 2020-09-18 | 成都天邦生物制品有限公司 | 全悬浮鸭胚视网膜细胞在鸡产蛋下降综合症疫苗中的应用 |
CN112251415A (zh) * | 2020-09-21 | 2021-01-22 | 成都天邦生物制品有限公司 | 一种鸡新城疫病毒分离方法 |
CN112156182A (zh) * | 2020-11-10 | 2021-01-01 | 成都天邦生物制品有限公司 | 一种全悬浮细胞源鸡新城疫、禽流感二联灭活疫苗 |
CN112359142A (zh) * | 2020-11-10 | 2021-02-12 | 成都天邦生物制品有限公司 | 一种使用全悬浮细胞测定鸡新城疫病毒含量的方法 |
CN113699119A (zh) * | 2020-12-10 | 2021-11-26 | 华农(肇庆)生物产业技术研究院有限公司 | 一种新城疫病毒及疫苗的无血清全悬浮培养制备方法 |
CN112626123A (zh) * | 2020-12-31 | 2021-04-09 | 华农(肇庆)生物产业技术研究院有限公司 | 重组质粒、重组基因vii型新城疫病毒及其培养方法 |
CN113122508A (zh) * | 2021-03-30 | 2021-07-16 | 成都天邦生物制品有限公司 | 一株鸡传染性支气管炎细胞适应毒及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110129281A (zh) | 一种使用悬浮细胞培养新城疫病毒的方法及应用 | |
CN110093307A (zh) | 适应无血清悬浮培养的bhk-21-sc细胞株和用该细胞株制备疫苗抗原的方法 | |
CN104258385A (zh) | Bhk-21细胞全悬浮培养技术在新城疫疫苗生产中的应用 | |
CN105664150B (zh) | 一种鸡新城疫病毒、禽流感病毒和禽腺病毒三联灭活疫苗 | |
CN108220227A (zh) | 一种通过全悬浮传代细胞系悬浮培养新城疫病毒的方法 | |
CN102260649A (zh) | 传染性法氏囊病毒及用鸡胚细胞系和生物反应器繁殖法氏囊病毒制备灭活疫苗和联苗的方法 | |
CN107412762A (zh) | 一种新城疫、禽流感、法氏囊和禽腺病毒四联疫苗 | |
CN108721615B (zh) | 一种制备鸭坦布苏病毒病灭活疫苗的方法及其疫苗 | |
CN105535958B (zh) | 一种鸡新城疫病毒、传染性支气管炎、禽腺病毒三联灭活疫苗 | |
CN104338127A (zh) | 一种h9n2亚型禽流感灭活疫苗的生产方法及其制品 | |
CN105582533A (zh) | 一种禽流感病毒、禽腺病毒二联灭活疫苗 | |
CN105274064B (zh) | 一种鸭坦布苏病毒弱毒疫苗株及其应用 | |
CN102727883B (zh) | 猪繁殖与呼吸综合征与猪瘟二联疫苗及其用途 | |
CN104689311A (zh) | 一种生产禽脑脊髓炎病毒灭活疫苗的方法 | |
CN108452298A (zh) | 一种用spf鸡胚细胞生产黄热病减毒活疫苗的工艺 | |
CN104087559B (zh) | 一种传染性法氏囊病毒、灭活疫苗及其制备方法 | |
CN103386127B (zh) | 用鸡胚传代细胞系和生物反应器培养新城疫病毒制备疫苗的方法 | |
CN102886043B (zh) | 猪乙型脑炎病毒与猪细小病毒二联灭活疫苗及其制备方法 | |
CN107823639A (zh) | 牛病毒性腹泻病毒灭活疫苗及其制备方法 | |
CN102268410B (zh) | 一株适应幼仓鼠肾传代细胞的新城疫病毒耐热弱毒株及其制备方法和应用 | |
CN109207436A (zh) | 一株i群4型禽腺病毒毒株及其应用 | |
CN104726409B (zh) | 一种永生化的鸭胚肝细胞系的制备方法和应用 | |
CN106237324A (zh) | 一种使用全悬浮技术生产猪传染性胃肠炎疫苗的方法 | |
CN103160475A (zh) | 一种肠道病毒71型病毒株及其用途、疫苗和制备方法 | |
CN107137705B (zh) | 猪伪狂犬gE基因缺失病毒灭活疫苗的生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant after: Chengdu Shiji biopharmaceutical Co.,Ltd. Applicant after: MA'ANSHAN SHIJI ANIMAL HEALTH MANAGEMENT Co.,Ltd. Address before: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant before: CHENGDU TECBOND BIOLOGICAL PRODUCTS CO.,LTD. Applicant before: MA'ANSHAN SHIJI ANIMAL HEALTH MANAGEMENT Co.,Ltd. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20221201 Address after: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant after: Chengdu Shiji biopharmaceutical Co.,Ltd. Address before: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant before: Chengdu Shiji biopharmaceutical Co.,Ltd. Applicant before: MA'ANSHAN SHIJI ANIMAL HEALTH MANAGEMENT Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190816 |
|
RJ01 | Rejection of invention patent application after publication |